A. Wagner

发表

Cis autocatalytic cleavage of glycine‐linked Zika virus NS2B‐NS3 protease constructs

U. Hellmich, T. Schirmeister, F. Hammerstein, 2019, FEBS letters.

Predicting 19F NMR Chemical Shifts: A Combined Computational and Experimental Study of a Trypanosomal Oxidoreductase–Inhibitor Complex

H. Schindelin, B. Engels, C. Ochsenfeld, 2020, Angewandte Chemie.

Peptidyl Vinyl Ketones Irreversible Inhibitors of Rhodesain: Modifications of the P2 Fragment.

U. Hellmich, T. Schirmeister, S. Cosconati, 2020, ChemMedChem.

Optimization strategy of novel peptide-based Michael acceptors for the treatment of Human African Trypanosomiasis.

U. Hellmich, T. Schirmeister, S. Cosconati, 2019, Journal of medicinal chemistry.

Backbone NMR assignments of tryparedoxin, the central protein in the hydroperoxide detoxification cascade of African trypanosomes, in the oxidized and reduced form

U. Hellmich, R. Krauth-Siegel, A. Wagner, 2017, Biomolecular NMR assignments.

New peptidomimetic rhodesain inhibitors with improved selectivity towards human cathepsins.

C. Sotriffer, U. Hellmich, T. Schirmeister, 2022, European journal of medicinal chemistry.

Drug Combination Studies of the Dipeptide Nitrile CD24 with Curcumin: A New Strategy to Synergistically Inhibit Rhodesain of Trypanosoma brucei rhodesiense

T. Schirmeister, Marta Bogacz, M. Zappalà, 2022, International journal of molecular sciences.

Some pharmacological properties of the false cholinergic transmitter acetylpyrrolidinecholine and its precursor pyrrolidinecholine

H. Kilbinger, A. Wagner, R. Zerban, 1976, Naunyn-Schmiedeberg's Archives of Pharmacology.

Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain

T. Schirmeister, S. Cosconati, Marta Bogacz, 2022, ACS medicinal chemistry letters.

New Cysteine Protease Inhibitors: Electrophilic (Het)arenes and Unexpected Prodrug Identification for the Trypanosoma Protease Rhodesain

S. Tenzer, B. Engels, Ute Distler, 2020, Molecules.

Crosstalk between angiotensin and the nonamyloidogenic pathway of Alzheimer's amyloid precursor protein

E. Kojro, M. Gütschow, R. Postina, 2017, The FEBS journal.

Naphthoquinones as Covalent Reversible Inhibitors of Cysteine Proteases—Studies on Inhibition Mechanism and Kinetics

S. Tenzer, B. Engels, Ute Distler, 2020, Molecules.

Backbone NMR assignments of tryparedoxin, the central protein in the hydroperoxide detoxification cascade of African trypanosomes, in the oxidized and reduced form

U. Hellmich, R. Krauth-Siegel, A. Wagner, 2017, Biomolecular NMR Assignments.

Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies.

S. Tenzer, B. Engels, Ute Distler, 2021, Journal of medicinal chemistry.

pH-Responsive protein nanoparticlesviaconjugation of degradable PEG to the surface of cytochromec

U. Hellmich, Johannes Ewald, H. Frey, 2020 .

Structure of the Human TRPML2 Ion Channel Extracytosolic/Lumenal Domain.

H. Schindelin, N. Morgner, U. Hellmich, 2019, Structure.

Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs).

J. Gut, P. Rosenthal, U. Hellmich, 2017, Journal of medicinal chemistry.

Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei rhodesiense.

U. Hellmich, T. Schirmeister, S. Cosconati, 2022, European journal of medicinal chemistry.

Inhibitor-Induced Dimerization of an Essential Oxidoreductase from African Trypanosomes.

H. Schindelin, B. Engels, U. Hellmich, 2019, Angewandte Chemie.

Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs).

J. Gut, P. Rosenthal, U. Hellmich, 2017, Journal of medicinal chemistry.